Amylyx Pharmaceuticals Inc (NAS:AMLX)
$ 3.87 -0.2 (-4.91%) Market Cap: 265.28 Mil Enterprise Value: 33.45 Mil PE Ratio: 0 PB Ratio: 1.35 GF Score: 21/100

Amylyx Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Jun 08, 2023 / 01:00PM GMT
Release Date Price: $26.25 (+0.42%)
Operator

Hello, and welcome to the Annual Meeting of Stockholders of Amylyx Pharmaceuticals, Inc. Please note, today's meeting is being recorded. During the meeting, we'll have a question-and-answer session. You can submit questions or comments at any time by clicking on the Q&A tab. It is now my pleasure to turn today's meeting over to Joshua Cohen, Chief -- Co-Chief Executive Officer and Co-Founder of Amylyx Pharmaceuticals. Mr. Cohen, the floor is yours.

Joshua B. Cohen
Amylyx Pharmaceuticals, Inc. - Co-Founder, Co-CEO & Director

Thank you. Good morning. I am Josh Cohen, Co-Chief Executive Officer and Co-Founder of Amylyx Pharmaceuticals, Inc., and I will act as Chairman of this meeting. I am pleased to welcome you to the Amylyx Pharmaceuticals, Inc. 2023 Annual Meeting of Stockholders. Before I call the meeting to order, I would like to note that the meeting will be conducted and questions will be considered in the manner outlined in the rules of conduct available on the virtual meeting website.

Stockholders can submit questions in writing during

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot